|
姓名 |
畢業年份 |
論 文 題 目 |
現職 |
|
G.R. Nirmal |
2022 |
Nanoparticles transduced near-infrared phototherapeutics for multimodal alleviation of psoriasiform lesions |
博後研究 (比利時 Ghent University) |
|
林承諭 |
2022 |
Targeting anti-inflammatory immunonanocarriers to human and murine neutrophils for psoriasiform dermatitis alleviation |
博後研究 (美國 Duke University) |
|
魏榯誸 |
2022 |
The effect of Chinese medicine compounds on the mitigation of atopic dermatitis |
研究助理 |
|
林姿瑋 |
2022 |
The development of conjugated linoleic acid-loaded nanocarriers for attenuating adipogenesis |
研究助理 |
|
簡旻瑜 |
2022 |
The combination of β-lactam antibiotics and platelet-rich plasma achieves synergistic bacterial eradication and skin regeneration in wound healing |
生技公司研發 |
|
李玫樺 |
2022 |
Multifunctional liposomes loaded with proteinase K and retinoic acid eradicate Cutibacterium acnes biofilm and reduce cutaneous proliferation for the aim of acne treatment |
生技公司研發 |
|
黃芷淇 |
2022 |
The effect of TiO2-containing mesoporous silica on the prevention of ultraviolet irradiation-induced skin aging and the adsorption of pollutants |
生技公司研發 |
|
黃昭容 |
2021 |
Cutaneous delivery of isoflavones for treating psoriasiform lesion |
研究助理 |
|
林芊郁 |
2021 |
Laser-assisted skin delivery of interleukin-6 siRNA-loaded nanocarriers for mitigating psoriasiform inflammation |
醫材公司研發 |
|
羅珮琦 |
2021 |
Laser-assisted skin delivery of retinoic acid-loaded polylactic acid/poly(lactic-co-glycolic acid) nanocarriers for treating photoaging |
研究助理 |
|
Thi My Huyen Nguyen |
2021 |
The anthraquinone compounds from rhubarb extract for mitigating psoriasiform inflammation |
生醫公司研發 |
|
陳韋彰 |
2021 |
The lipolysis activity of the compounds from rhubarb extract |
研究助理 |
|
李賢儒 |
2021 |
Bioactive effect of curcumin and its naturally occurring derivatives on 3T3-L1 adipocytes |
健康食品公司研發 |
|
林資展 |
2020 |
The investigation of novel anti-psoriatic agents: PDE4 inhibitors and active-targeting nanocarriers |
長庚科大研究員 |
|
吳智元 |
2020 |
Development of sunscreen-loaded mesoporous silica for protecting ultraviolet irradiation and air pollutant invasion |
藥廠 R&D |
|
鄭文婷 |
2020 |
Ablative lasers promote the skin delivery of platelet-rich plasma |
生技公司 R&D |
|
巫鈺茹 |
2020 |
Immune regulatory effect of tumor-infiltrating lymphocytes (TILs) and glioma-associated macrophages/microglia (GAMs) in glioma |
美國博後研究 |
|
連婉媜 |
2019 |
The establishment of structure-permeation relationship: flavanones and benzoxazinone derivative as the examples |
藥廠R&D |
|
Ani Umoro |
2019 |
The effect of lipid nanocarriers with different particle sizes for suppressing human neutrophil activation: Acute lung injury as a disease model |
印尼藥廠 |
|
楊雨青 |
2019 |
The drug-resistant pathogen inhibition by cationic nanoemulsions and furanoquinone derivatives |
研究助理 |
|
林婕瑀 |
2019 |
The relationship between percutaneous absorption and skin toxicity of polycyclic aromatic hydrocarbon compounds |
藥廠 R&D |
|
陳君漢 |
2018 |
Absorptive and therapeutic impacts of silymarin-loaded nanocarriers on post-gastric bypass surgery and obesity animals |
嘉義長庚醫師 |
|
劉珮瑩 |
2018 |
Fractional lasers for promoting the cutaneous absorption of macromolecules: diseased skins as the diffusion barriers |
研究助理 |
|
陳雅萍 |
2018 |
Cationic nanostructured lipid carriers as the vehicles of oxacillin for improving the inhibitory activity against drug-resistant bacteria |
藥廠 R&D |
|
陳恩立 |
2017 |
The establishment of structure-permeation relationship: tricyclic antidepressants and flavonoids as the examples |
研究助理 |
|
林承諭 |
2017 |
Development of cilomilast-loaded nanoformulations for inhibiting neutrophil activation: lipid nanoparticles and niosomes |
博後研究 |
|
黃昌尉 |
2016 |
Enhancement strategies of topical retinoic acid delivery: non-ablative fractional laser and co-drug |
藥廠研發管理 |
|
翁依涵 |
2016 |
New formulations and compounds for anti-MRSA therapy: malleable liposomes and natural products |
儀器公司研發 |
|
戴攸珊 |
2016 |
Passive and active targeting of silibinin-loaded nanocarriers for treating hepatic fibrosis |
生技公司研發 |
|
廖偉君 |
2016 |
Methylation and esterification of magnolol for ameliorating cutaneous targeting and therapeutic index by topical application |
生技公司研發管理 |
|
胡凱茵 |
2015 |
Design and development of nanocarriers for drug targeting to pulmonary tissue |
研究助理 |
|
高筱晴 |
2015 |
The cutaneous delivery of drugs via diseased skins: psoriasis and atopic dermatitis as examples |
醫美儀器產品專員 |
|
黃淳麟 |
2014 |
Development and investigation of multi-functional nanosystems for integrating bioimaging and drug delivery |
研究助理 |
|
張書豪 |
2014 |
Transdermal delivery systems of ketorolac ester prodrugs and hydroquinone-salicylic acid co-drugs |
財團法人藥技中心 |
|
施惠琪 |
2014 |
Establishment of skin permeability profiles for drug and sunscreen absorption via photoaging skin |
生技公司研發 |
|
洪宜筠 |
2013 |
Evaluation of skin response treated by bioactive and toxic compounds using different experimental platforms: magnolol/honokiol and phthalates as the permeants |
藥廠業務代表 |
|
黃雅慧 |
2013 |
Pharmacokinetics and bioimaging of nanostructured lipid carriers for anti-inflammation and angiography |
生技公司研發 |
|
沈逢鳴 |
2013 |
Preparation and evaluation of lipid nanoparticles for targeting to hair follicles |
藥廠產品經理 |
|
張媛婷 |
2013 |
The effect of cationic nanosystems in human neutrophils |
藥廠業務代表 |
|
李怡靜 |
2012 |
Influence of resurfacing laser on skin delivery of drugs: the risk of excessive drug absorption and enhancement of skin permeability |
生技公司企劃 |
|
陳浚責 |
2012 |
The co-drugs of conjugated hydroquinone/azelaic acid and hysroquinone/tranexamic acid for enhancing topical skin targeting and decreasing penetration through skin |
藥廠專案管理 |
|
袁丞音 |
2012 |
Transdermal drug delivery enhanced by fractional erbium:YAG laser |
美國進修博士學位 |
|
楊詩韻 |
2011 |
Evaluation of drug and sunscreen permeation via skin irradiated with UVA and UVB: comparisons of normal skin and chronologically aged skin |
生技公司品管分析師 |
|
古明娟 |
2011 |
Development and evaluation of drug delivery systems for apomorphine and its prodrugs |
藥廠研發 |
|
張惠雯 |
2010 |
Mechanistic studies of the skin delivery of lipid colloid systems with different oil/fatty ester ratios for both lipophilic and hydrophilic drugs |
藥廠產品經理 |
|
張力文 |
2010 |
Topical/transdermal delivery of natural antioxidants |
藥廠研發企劃 |
|
陳朝煌 |
2009 |
The physicochemical characteristics and pharmacokinetics of water-in-oil emulsions encapsulated with anti-bladder cancer drugs via intravesical route |
社區藥局藥師 |
|
蔡佳音 |
2009 |
Delivery of buprenorphine and its prodrugs formulated by lipid nanoparticles |
醫院藥師 |
|
紀政嫻 |
2009 |
The development and evaluation on drug delivery systems for anti-Parkinson’s drugs: nano-carriers for injection and transdermal delivery formulation |
分析檢驗公司講師 |
|
陳志杰 |
2009 |
Permeability and proteomicprofiles of heavy metals delivered by skin route |
粧品公司負責人 |
|
卓柔孜 |
2008 |
Enhancement of transdermal drug delivery by erbium:YAG Laser: peptides, vaccine, and anti-psoriatic Drug |
生技公司研發 |
|
蘇鈺涵 |
2008 |
The physicochemical characterization and drug delivery of lipid nanoparticles for topical and injectable dosage forms |
研究助理 |
|
黃梓柔 |
2008 |
Development and evaluation of resveratrol and soy Isoflavones in topical/transdermal delivery systems |
CRO 研究主管 |
|
葉智惠 |
2007 |
Design and characterization of drug delivery systems for narcotic prodrugs |
藥廠研發 |
|
花淑秋 |
2007 |
Development and investigation of nano-or submicron-sized vesicles for encapsulating cisplatin and camptothecin |
醫院藥師 |
|
胡濬文 |
2007 |
The thermo-sensitive hydrogels containing chitosan, hyaluronic acid and alginate as drug delivery systems |
生技公司研發主管 |
|
廖美惠 |
2006 |
Drug delivery and in vivo efficacy of resveratrol from nano/submicron encapsulated formulations |
藥廠業務代表 |
|
劉靜儒 |
2006 |
Transdermal delivery of drugs and genes enhanced by microdermabrasion and Er:YAG laser |
藥廠產品專員 |
|
黃妍菱 |
2005 |
The physicochemical characteristics and in vivo pharmacokinetics of tea catechins encapsulated with liposomes |
美國 |
|
翁玟雯 |
2005 |
Enhancing percutaneous absorption of theophylline and tea catechins by chemical and physical methods |
醫院藥師 |
|
王新元 |
2005 |
Hydrogels as drug carriers for both micro- and macromolecules |
藥師 |
|
張嘉駿 |
2004 |
Nano/submicron lipid emulsions composed of natural oils modulate drug and gene delivery |
中醫師 |
|
方逸萍 |
2004 |
Transdermal delivery of anti-cancer drugs promoted by physical enhancements |
高醫大副教授 |
|
邱顯智 |
2003 |
Evaluation of efficacy and safety on skin permeation enhancers: flurbiprofen and curcumin as model drugs |
馬來西亞生技公司主管 |
|
鄭曉菁 |
2003 |
Development of essential oils from Alpinia oxyphylla and Ocimum basilicum as novel skin permeation enhancers |
藥廠研發 |